Emerging concepts on bradykinesia in non-parkinsonian conditions

被引:31
|
作者
Paparella, Giulia [1 ]
Fasano, Alfonso [2 ,3 ,4 ]
Hallett, Mark [5 ]
Berardelli, Alfredo [1 ,6 ]
Bologna, Matteo [1 ,6 ]
机构
[1] IRCCS Neuromed, Pozzilli, Italy
[2] Univ Hlth Network, Toronto Western Hosp, Morton & Gloria Shulman Movement Disorders, Edmond J Safra Program Parkinsons Dis, Toronto, ON, Canada
[3] Univ Toronto, Div Neurol, Toronto, ON, Canada
[4] Krembil Brain Inst, Toronto, ON, Canada
[5] Natl Inst Neurol Disorders & Stroke, Human Motor Control Sect, NIH, Bethesda, MD USA
[6] Sapienza Univ Rome, Dept Human Neurosci, Viale Univ 30, I-00185 Rome, Italy
关键词
bradykinesia; cerebellar diseases; dementia; hyperkinetic disorders; motor neuron diseases; MILD COGNITIVE IMPAIRMENT; AMYOTROPHIC-LATERAL-SCLEROSIS; MOVEMENT-RELATED POTENTIALS; MOTOR-NEURON DISEASE; ESSENTIAL TREMOR; MULTIPLE-SCLEROSIS; BASAL GANGLIA; HUNTINGTONS-DISEASE; KINEMATIC ANALYSIS; CERVICAL DYSTONIA;
D O I
10.1111/ene.14851
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose Bradykinesia is one of the cardinal motor symptoms of Parkinson's disease. However, clinical and experimental studies indicate that bradykinesia may also be observed in various neurological diseases not primarily characterized by parkinsonism. These conditions include hyperkinetic movement disorders, such as dystonia, chorea, and essential tremor. Bradykinesia may also be observed in patients with neurological conditions that are not seen as "movement disorders," including those characterized by the involvement of the cerebellum and corticospinal system, dementia, multiple sclerosis, and psychiatric disorders. Methods We reviewed clinical reports and experimental studies on bradykinesia in non-parkinsonian conditions and discussed the major findings. Results Bradykinesia is a common motor abnormality in non-parkinsonian conditions. From a pathophysiological standpoint, bradykinesia in neurological conditions not primarily characterized by parkinsonism may be explained by brain network dysfunction. Conclusion In addition to the pathophysiological implications, the present paper highlights important terminological issues and the need for a new, more accurate, and more widely used definition of bradykinesia in the context of movement disorders and other neurological conditions.
引用
收藏
页码:2403 / 2422
页数:20
相关论文
共 50 条
  • [41] Role of the frequency of STN stimulation on bradykinesia in Parkinsonian patients
    Zacharia, A.
    Sastre, I.
    Georgiev, D.
    Hariz, M.
    Zrinzo, L.
    Foltynie, T.
    Jahanshahi, M.
    Rothwell, J.
    Limousin, P.
    MOVEMENT DISORDERS, 2015, 30 : S248 - S248
  • [42] Olfactory bulb surroundings can help to distinguish Parkinson's disease from non-parkinsonian olfactory dysfunction
    Tremblay, Cecilia
    Mei, Jie
    Frasnelli, Johannes
    NEUROIMAGE-CLINICAL, 2020, 28
  • [43] The diagnostic accuracy of DAT SPECT using DaTQUANT software: discrimination among patients with non-Parkinsonian disease, Parkinson's disease, and atypical Parkinsonian syndromes
    Iwabuchi, Y.
    Nakahara, T.
    Kameyama, M.
    Yamada, Y.
    Hashimoto, M.
    Matsusaka, Y.
    Jinzaki, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S401 - S401
  • [44] Olfactory bulb volume in Parkinson's Disease olfactory dysfunction when compared to non-parkinsonian olfactory dysfunctions.
    Tremblay, Cecilia
    Lafontaine, Emilie
    Steffener, Jason
    Frasnelli, Johannes
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2020, 79 (06): : 695 - 696
  • [45] Case Report: GPi DBS for Non-parkinsonian Midline Tremor: A Normative Connectomic Comparison to a Failed Thalamic DBS
    Morishita, Takashi
    Sakai, Yuki
    Mishima, Takayasu
    Umemoto, George
    Okun, Michael S.
    Tanaka, Saori C.
    Tsuboi, Yoshio
    Inoue, Tooru
    FRONTIERS IN HUMAN NEUROSCIENCE, 2021, 15
  • [46] Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts
    Usman Saeed
    Jordana Compagnone
    Richard I. Aviv
    Antonio P. Strafella
    Sandra E. Black
    Anthony E. Lang
    Mario Masellis
    Translational Neurodegeneration, 6
  • [47] Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts
    Saeed, Usman
    Compagnone, Jordana
    Aviv, Richard I.
    Strafella, Antonio P.
    Black, Sandra E.
    Lang, Anthony E.
    Masellis, Mario
    TRANSLATIONAL NEURODEGENERATION, 2017, 6
  • [48] The effect of Mozart piano sonata on Parkinsonian tremor, rigidity and bradykinesia
    Shoeybi, A.
    Olfati, N.
    MOVEMENT DISORDERS, 2016, 31 : S622 - S623
  • [49] Evaluation for Parkinsonian Bradykinesia by deep learning modeling of kinematic parameters
    Dong Jun Park
    Jun Woo Lee
    Myung Jun Lee
    Se Jin Ahn
    Jiyoung Kim
    Gyu Lee Kim
    Young Jin Ra
    Yu Na Cho
    Weui Bong Jeong
    Journal of Neural Transmission, 2021, 128 : 181 - 189
  • [50] Oxidation of dopamine and related catechols in dopaminergic brain regions in Parkinson's disease and during ageing in non-Parkinsonian subjects
    Wallin, Bodil Fornstedt
    JOURNAL OF NEURAL TRANSMISSION, 2024, 131 (03) : 213 - 228